(Q42657903)

4 November 2017

title

Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia (English)

1 reference

4 November 2017

0 references

1 reference

Olsson AG

1

1 reference

4 November 2017

Pears J

2

1 reference

4 November 2017

McKellar J

3

1 reference

4 November 2017

Mizan J

4

1 reference

4 November 2017

Raza A

5

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

American Journal of Cardiology

4 November 2017

published in

1 reference

4 November 2017

volume

88

1 reference

4 November 2017

issue

5

1 reference

4 November 2017

page(s)

504-508

1 reference

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901727-1

Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901727-1

Current perspectives on statins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901727-1

Drug treatment of lipid disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901727-1

Statins: effective antiatherosclerotic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901727-1

Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901727-1

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901727-1

Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901727-1

10.1016/S0002-9149(01)01727-1

7 January 2021

Identifiers

DOI

1 reference

4 November 2017

1 reference